Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 1;77(3):331-336.
doi: 10.1097/QAI.0000000000001609.

Rapid Serological Tests Ineffectively Screen for HIV Exposure in HIV-Positive Infants

Brittany Urick  1 , Youyi Fong  2 , Christopher Okiira  3 , Nicolette Nabukeera-Barungi  4 , Denis Nansera  5 , Emmanuel Ochola  6 , Julius Nteziyaremye  7 , Victor Bigira  1 , Isaac Ssewanyana  2 , Peter Olupot-Olupot  7 , Trevor Peter  1 , Anisa Ghadrshenas  1 , Lara Vojnov  1 , Charles Kiyaga  3
Affiliations

Rapid Serological Tests Ineffectively Screen for HIV Exposure in HIV-Positive Infants

Brittany Urick et al. J Acquir Immune Defic Syndr. .

Abstract

Background: Data on the performance and utility of rapid serological tests in infants to determine HIV exposure are unclear and in some instances contradictory. This study sought to understand the performance of rapid serological tests in high HIV burden, high Option B+ coverage settings to be used as an HIV exposure screening tool.

Methods: A total of 3600 infants up to 24 months of age at 4 regional hospitals in Uganda were systematically enrolled and tested simultaneously using both HIV rapid serological and nucleic acid-based tests.

Results: Only 58 of the 94 HIV-positive infants who received both rapid serological and nucleic acid-based tests were positive with the rapid serological test (sensitivity: 61.7%; 95% confidence interval: 51.1 to 71.5). Using rapid serological tests to screen infants for exposure to HIV and follow-up nucleic acid-based testing would have missed 38.3% (36 of 94) of HIV-positive infants. Finally, several HIV-positive infants who were negative by rapid serological test presented to well-child entry points and were considered healthy. All 3 HIV-positive infants presenting to outreach and immunization were negative by rapid serological testing and 73% (8 of 11) presenting to outpatient.

Conclusions: These data suggest that the use of rapid serological tests may have inadequate performance as an indicator of exposure and potential HIV infection among infants presenting at both well-child (immunization and community outreach) and sick-infant (nutrition and inpatient) entry points. To improve the identification of HIV-positive infants, nucleic acid-based testing should instead be considered in infants aged younger than 18 months.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of age by all and rapid serological test outcome among HIV-positive infants.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. UNAIDS. On the Fast-Track to an AIDS-free Generation. 2016.
    1. Bourne DE, Thompson M, Brody LL, et al. Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS. 2009;23(1):101–106. - PubMed
    1. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-positive mothers in Africa: a pooled analysis. Lancet. 2004;364(9441):1236–1243. - PubMed
    1. Kabue M, Buck WC, Wanless SR, et al. Mortality and clinical outcomes in HIV-positive children on antiretroviral therapy in Malawi, Lesotho, and Swaziland. Pediatrics. 2012;130(3):e591–9. - PMC - PubMed
    1. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-positive infants. N Engl J Med. 2008;359(21):2233–2244. - PMC - PubMed

Publication types